OVERLAND THERAPEUTICS

Serial Number 98176089
Registration 7628090
700

Registration Progress

Application Filed
Sep 12, 2023
Under Examination
Aug 6, 2024
Approved for Publication
Jun 11, 2024
Published for Opposition
Jun 11, 2024
Registered
Dec 24, 2024

Trademark Image

OVERLAND THERAPEUTICS

Basic Information

Serial Number
98176089
Registration Number
7628090
Filing Date
September 12, 2023
Registration Date
December 24, 2024
Published for Opposition
June 11, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 24, 2024
Registration
Registered
Classes
042

Rights Holder

OVERLAND THERAPEUTICS (US) INC.

03
Address
280 UTAH AVE, SUITE 250
SOUTH SAN FRANCISCO, CA 94080

Ownership History

OVERLAND PHARMACEUTICALS (US) INC.,

Original Applicant
03
South San Francisco, CA

OVERLAND PHARMACEUTICALS (US) INC.,

Owner at Publication
03
South San Francisco, CA

OVERLAND THERAPEUTICS (US) INC.

New Owner After Publication #1
03
SOUTH SAN FRANCISCO, CA

OVERLAND THERAPEUTICS (US) INC.

Original Registrant
03
SOUTH SAN FRANCISCO, CA

Legal Representation

Attorney
Enshan Hong

USPTO Deadlines

Next Deadline
1983 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-24)
Due Date
December 24, 2030
Grace Period Ends
June 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Dec 28, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 28, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 28, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 28, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 28, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 24, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 24, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 2, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 2, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 26, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 26, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 20, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 20, 2024 IUAF S USE AMENDMENT FILED Loading...
Aug 6, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 11, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jun 11, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 11, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 22, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 7, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 7, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 2, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 15, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical and pharmaceutical research services; pharmaceutical research and development
First Use Anywhere: Sep 20, 2024
First Use in Commerce: Sep 20, 2024

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"